Can platelet-rich plasma enhance tendon repair? A cell culture study

American Journal of Sports Medicine

Volumn 36, Issue 6, 2008, Pages 1171-1178

  De Mos, Marieke ^a   Van Der Windt, Anna E ^a   Jahr, Holger ^a   Van Schie, Hans T M ^a,b   Weinans, Harrie ^a   Verhaar, Jan A N ^a   Van Osch, Gerjo J V M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Collagen; Growth factors; Matrix metalloproteinases; Platelet rich plasma; Tendon

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; GROWTH FACTOR; INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR BB; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD DONOR; CATABOLISM; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TENDON INJURY; TENDON RECONSTRUCTION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; UPREGULATION;

CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; DNA; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASES; PLATELET-RICH PLASMA; TENDONS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 44049097227     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546508314430     Document Type: Article

References (33)

1. Akeda K., An HS, Okuma M., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006: 14: 1272-1280.
2. Alfredson H., Lorentzon M., Backman S., Backman A., Lerner UH cDNAarrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res. 2003 ; 21: 970-975.
3. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999 ; 14: 529-535.
4. Anitua E., Andia I., Sanchez M., et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005 ; 23: 281-286.
5. Annunziata M., Oliva A., Buonaiuto C., et al. In vitro cell-type specific biological response of human periodontally related cells to platelet-rich plasma. J Periodontal Res. 2005 ; 40: 489-495.
6. Aspenberg P., Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004 ; 75: 93-99.
7. Conway EM, Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001 ; 49: 507-521.
8. Creemers LB, Jansen DC, van Veen-Reurings A., van den Bos T., Everts V. Microassay for the assessment of low levels of hydroxyproline. Biotechniques. 1997 ; 22: 656-658.
9. de Mos M., van El B., Degroot J., et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med. 2007 ; 35: 1549-1556.
10. DelRossi AJ, Cernaianu AC, Vertrees RA, et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990 ; 100: 281-286.
11. Eijken M., Hewison M., Cooper MS, et al. 11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol Endocrinol. 2005 ; 19: 621-631.
12. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004 ; 114: 1502-1508.
13. Eriksen HA, Pajala A., Leppilahti J., Risteli J. Increased content of type III collagen at the rupture site of human Achilles tendon. J Orthop Res. 2002 ; 20: 1352-1357.
14. Fenwick SA, Hazleman BL, Riley GP The vasculature and its role in the damaged and healing tendon. Arthritis Res. 2002 ; 4: 252-260.
15. Hee HT, Majd ME, Holt RT, Myers L. Do autologous growth factors enhance transforaminal lumbar interbody fusion ? Eur Spine J. 2003 ; 12: 400-407.
16. Ireland D., Harrall R., Curry V., et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol. 2001 ; 20: 159-169.
17. Jarvinen TA, Kannus P., Maffulli N., Khan KM Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin. 2005 ; 10: 255-266.
18. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum. 2006 ; 54: 832-842.
19. Kannus P., Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon: a controlled study of 891 patients. J Bone Joint Surg Am. 1991 ; 73: 1507-1525.
20. Knighton DR, Ciresi K., Fiegel VD, Schumerth S., Butler E., Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet. 1990 ; 170: 56-60.
21. Livak KJ, Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 ; 25: 402-408.
22. Maffulli N., Ewen SW, Waterston SW, Reaper J., Barrass V. Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons: an in vitro model of human tendon healing. Am J Sports Med. 2000 ; 28: 499-505.
23. Margolis DJ, Kantor J., Santanna J., Strom BL, Berlin JA Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001 ; 24: 483-488.
24. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 ; 34: 1774-1778.
25. Molloy T., Wang Y., Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003 ; 33: 381-394.
26. Petersen W., Pufe T., Zantop T., Tillman B., Tsokos M., Mentlein R. Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. Clin Orthop Relat Res. 2004 ; 420: 286-291.
27. Pietrzak WS, Eppley BL Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005 ; 16: 1043-1054.
28. Pufe T., Petersen WJ, Mentlein R., Tillmann BN The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand J Med Sci Sports. 2005 ; 15: 211-222.
29. Riley GP, Curry V., DeGroot J., et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002 ; 21: 185-195.
30. Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007 ; 25: 230-240.
31. Scott A., Ashe MC Common tendinopathies in the upper and lower extremities. Curr Sports Med Rep. 2006 ; 5: 233-241.
32. Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc. 2003 ; 69: 664.
33. Yoshikawa T., Tohyama H., Katsura T., et al. Effects of local administration of vascular endothelial growth factor on mechanical characteristics of the semitendinosus tendon graft after anterior cruciate ligament reconstruction in sheep. Am J Sports Med. 2006 ; 34: 1918-1925.